CD91:XETRA:XETRA-Amundi Index Solutions - Amundi NYSE Arca Gold BUGS UCITS ETF USD Distributing (EUR)

ETF | Others |

Last Closing

USD 35.985

Change

+1.88 (+5.50)%

Market Cap

USD 0.28B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.12 (-0.27%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.03 (+0.02%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.18 (-0.77%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.08 (-0.62%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.03 (-0.63%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.14 (-0.58%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.01 (+0.04%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

N/A

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.01 (-0.06%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.41 (-0.34%)

USD 12.26B

ETFs Containing CD91:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 38.67% 99% N/A 97% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.67% 99% N/A 96% N/A
Trailing 12 Months  
Capital Gain 41.67% 97% N/A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.67% 97% N/A 95% A
Trailing 5 Years  
Capital Gain 55.78% 63% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 55.78% 63% D 63% D
Average Annual (5 Year Horizon)  
Capital Gain 4.75% 46% F 47% F
Dividend Return 4.99% 45% F 46% F
Total Return 0.24% 35% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 20.93% 16% F 29% F
Risk Adjusted Return 23.86% 31% F 37% F
Market Capitalization 0.28B 59% D- 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.